Analysts expect Protagonist Therapeutics, Inc to report revenue of 233.96 M for Q3 26, against a range of 226.90 M to 241.01 M. The most recent reported quarter, Q2 26, came in at 213.47 M, a 11.0% beat against the 192.23 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.67 M | 170.64 M | 28.30 M | 5.55 M | 4.71 M | 7.44 M | 56.37 M | 213.47 M | - | - | - | - |
| High Estimate | 3.49 M | 130.55 M | 42.67 M | 8.63 M | 3.71 M | 9.71 M | 15.03 M | 205.66 M | 241.01 M | 39.97 M | 50.24 M | 59.09 M |
| Low Estimate | 3.02 M | 117.00 M | 35.48 M | 7.21 M | 3.19 M | 8.79 M | 12.80 M | 178.81 M | 226.90 M | 33.67 M | 43.53 M | 50.77 M |
| Consensus Estimate | 3.25 M | 123.77 M | 39.08 M | 7.92 M | 3.45 M | 9.25 M | 13.92 M | 192.23 M | 233.96 M | 36.82 M | 46.89 M | 54.93 M |
Analysts expect Protagonist Therapeutics, Inc to report earnings per share of 2.34 for Q3 26, against a range of 2.20 to 2.48. The most recent reported quarter, Q2 26, came in at 2.29, a 6.0% beat against the 2.16 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.54 | 1.98 | -0.19 | -0.55 | -0.62 | -0.69 | 0.05 | 2.29 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.58 | 1.16 | -0.19 | -0.52 | -0.56 | -0.52 | -0.47 | 2.28 | 2.48 | -0.23 | -0.13 | -0.03 | 1.30 | -0.41 | -0.20 | 0.46 | ||||||||||
| Low Estimate | -0.62 | 1.04 | -0.23 | -0.60 | -0.66 | -0.58 | -0.51 | 2.04 | 2.20 | -0.27 | -0.15 | -0.03 | 1.18 | -0.49 | -0.22 | 0.38 | ||||||||||
| Consensus Estimate | -0.60 | 1.10 | -0.21 | -0.56 | -0.61 | -0.55 | -0.49 | 2.16 | 2.34 | -0.25 | -0.14 | -0.03 | 1.24 | -0.45 | -0.21 | 0.42 |
Pull Wall Street consensus for Protagonist Therapeutics, Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PTGX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PTGX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PTGX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();